Ablacon Company

Ablacon is a provider of AI-guided atrial fibrillation therapies.

Last Funding Type: Post-IPO Equity
Headquarters: Wheat Ridge, Colorado, United States
Founded Date: 2015
Investor Type: contact@ablacon.com
Total Funding: $6.8B
Technology: ['BioTech & HealthTech']
Estimated Revenue: $50M to $100M
Investors Number: 7
Industry: Med Tech